Tender For empanelment of cathlab items - des, everolium, fda approved platinum chromium platform poly-vunylicene fluoride, des, everolimus ,fda approved cobalt chromium platform stent length up to 38 mm, des everolimus for approved cto stent cobalt chromium platform stent 2.25mm to 4.25mm diameter, des, everolimus, fda afproved platinum chromium platform, bioabsorbable polymer plga, des, everolimus fda approved cobalt chromium platform stent length from 12 mm upto 38 mm, des, everolimus hypotube halloon technology, fda approved cobalt chromium platform stem length up to 48 mm, des, everolimus, fda approved cto stent cobalt chromium platform, fluoropolymer z:25mm to 4:25mm, des everolimus, only dcgi cobalt chromium platform, 50 micron strut thickness, des everolimus, only ce afproved cobalt chromium platform with 65 to 70 micron strut, des, everolimus, only degi cobalt chromium platform with 60 micron strut, des everolimus, ce/fda/dcgi approved cobalt chromium biodegradable polymer, 60 micron strut with z link technology and tetrinium design with cumulative drug release technology: length: 8.12.16.20,24 28.32.36.40.44.48, des, biolimus fda approved cobalt chromium platform, des biolimus, ce approved cobalt chromium platform, des, biolimus, only dcgi approved cobalt chromium platform 60 micron strut thickness, des zotarolimus, fda approved cobalt chromium platform polymer type-biolinx, des zotarolimus, ce approved cobalt chromium platform polymer type-phosphorylcholine, des zotarolimus, only dcgi cobalt chromium platform hydrophilic polymer, des zotardlimus eluting coronary stent system with core wire and continuous sinsoid technology, des dual drug eluting polymer free stent, bms fda approved cobalt chromium platform, bms only dcgiapproved cobalt chromium platform, bifurcation stent self expanding, nitinol, bifurcation stent balloon expanding, platinum chromium, bifurcation stent sirolimus eluting,cobalt chromium, bifurcation stent paclitaxel eluting,cobalt chromium, tapered des sirolimus coranary stent with biodegradable polymer, des sirolimus, ce and fda approved, cobalt chromium platform, biodegradable plla eluting 60 mcg strut thickness,cumulative drug release technology with high trackability, des sirolimus, ce approved stainless steel platform, des, sirolimus, only dcgi approved stainless steel platform 50 micron strut thicknes, des sirolimis, 65 micron strut hybrid design with proximal main branch segment and distal tapered side branch segment, sirolimus eluting conorary stent system with an 65 um strut thickness, delivery system with manolithic distal shaft design elongated des sirolimus, ce approved, cobalt chromium platform, abluminal biodegradable polymer eluted in the grooves, des,sirolimus, ce approved, cobalt chromium platform,abluminal biodegradable polymer eluted in the grooves, coronary self apposing stent, multilink cobalt-chromium, meshed stent, ptfe covered stent stainless steel, rapid exchange type, sizes 28, 35.4.4.5.4.8mm, usable length 143cm,crimped stent profile 0.068 inch, biodegradable vascular scaffold (bvs) everolimus eluting, biodegradable vascular scaffold (bvs) sirolimus eluting, stainless steel abluminally coated sirolimus eluting coronary stent with microporous surface & low biodegradable polymer with temperature controlled packing and temperature monitoring device-ce approved, polymer free dual drug sirolimus and probucol eluting stent technology with microporous surface abluminal coating and shellac resin with diameters 2mm-4mm and length 8mm-48mm-dcgi approve, cobalt chromium abluminally coated sirolimus eluting coronary stent with microporous surface & low biodegradable polymer -ce approved, stainless steel abluminally coated sirolimus eluting coronary stent with microporous surface & low biodegradable polymer ce approved, des, sirolimus, ce approved stainless steel platform, prma / peva double layer polymer coating for optimal drug release control,90 days drug releasing, flexible stent d
20 Dec, 2024
1.00 Crore
